Agarwal N, Tangen CM, Hussain MHA, Gupta S, et al. Orteronel for Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter, Randomized, Open-Label Phase III Trial (SWOG-1216). J Clin Oncol 2022 Apr 21:JCO2102517. doi: 10.1200/JCO.21.02517.
PMID: 35446628